NuVision Biotherapies is delighted to announce the appointment of its new chairman, Dr Mark Treherne. Mark has a PhD in Pharmacology from Cambridge University along with over 25 years of industrial R&D experience in the discovery and development of novel treatments for diseases with unmet medical...
Staffordshire University are hosting a number of employer focused events. If you would like to find out more about Staffordshire University and our Apprenticeships click this link. New recruits and existing employees are eligible to be a higher or degree apprentice. Apprentices can study for a...
A unique technology for the construction industry offering immersive “walk throughs” of unbuilt houses; a novel method of recycling print toner powder for use across a range of applications including art, construction and animal medicines; and a technique for new drug discovery are among the...
East Midlands companies are invited to apply for a Medilink East Midlands Business Award for 2018. Open to businesses who work in, service or supply to the Life Sciences, Healthcare, Medical Technology, Digital Health, Pharmaceutical & Biotechnology sectors. The aim of our awards is to highlight the...
XenoGesis is teaming up with Sygnature Discovery and DMDG to host the forthcoming meeting on predictive toxicology in Discovery DMPK. The meeting will provide a forum for the exchange of ideas between members of the DMPK and toxicology research communities. The event will bring together talks...
Locate Therapeutics, a leading UK regenerative medicine company has announced that it has successfully achieved EN ISO 13845:2016 certification for the design control and control of manufacturing of resorbable injectable tissue scaffolds for use in bone repair and regeneration. Locate Therapeutics are a biomaterials-focussed company that...
Leading UK-based DMPK provider has taken tenancy at BioHub, Alderley Park, increasing its foothold in the UK. XenoGesis which was founded in 2011 by Dr Richard Weaver, has seen continued growth at its headquarters at BioCity Nottingham. Now employing 25 members of staff, the business has...
NuVision Biotherapies, based at BioCity Nottingham, is a regenerative medicine company who have developed a groundbreaking therapy that can help prevent sight loss. This week they have completed a £500,000 funding round backed by Mercia Fund Managers, angel investors and the University of Nottingham. The investment...
The ClinSpec Dx - Triage ID system has now been installed at Western General Hospital in Edinburgh and is currently recruiting prospective patients for a clinical feasibility study, alongside the Wellcome Trust. Patients with a suspected brain tumour will be recruited for their simple blood test,...
To accelerate the industrialisation of OTFT technology in China and its application to flexible displays, sensors and IoT markets, NeuDrive and Cocoon have founded Xinqu Chuangrou Photoelectric Technology Limited in Hubei Province. NeuDrive will provide intangible assets including patents and know-how with Cocoon providing the financial...